Literature DB >> 2788994

Primary prevention of chronic diseases in adolescence: effects of the Midwestern Prevention Project on tobacco use.

M A Pentz1, D P MacKinnon, B R Flay, W B Hansen, C A Johnson, J H Dwyer.   

Abstract

This article reports six-month, one-year, and two-year effects of a longitudinal multicomponent community program directed toward delaying the onset of cigarette smoking in adolescence. Results are based on a longitudinal panel of sixth and seventh grade students from eight schools in the Kansas City Standard Metropolitan Statistical Area (n = 1,122). In the fall of 1984, schools were assigned to either a program group, which received school, booster, parent, and mass media program components, or a control group that received regular health education programming in school and mass media exposure. By six months, there was a significant effect of the program on recent smoking, with the prevalence of smokers in the program group increasing more slowly than in the control group. At two years, 19% of students in the program group reported smoking in the last month versus 29% of students in the control group; and 12% versus 19%, respectively, reported smoking in the last week. The lifetime prevalence rate showed a marginal program effect at two years, with 57% of students in the program group having smoked once or more compared with 65% in the control group. The program was also effective across different levels of cigarette use ranging from no current use to use of one pack or more per day at two years.

Entities:  

Mesh:

Year:  1989        PMID: 2788994     DOI: 10.1093/oxfordjournals.aje.a115393

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  A randomised controlled trial of a community intervention to prevent adolescent tobacco use.

Authors:  A Biglan; D V Ary; K Smolkowski; T Duncan; C Black
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

Review 2.  Investing in youth tobacco control: a review of smoking prevention and control strategies.

Authors:  P M Lantz; P D Jacobson; K E Warner; J Wasserman; H A Pollack; J Berson; A Ahlstrom
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

3.  Adolescent substance abuse prevention programs: Theories, models, and research in the encouraging 80's.

Authors:  E Norman; S Turner
Journal:  J Prim Prev       Date:  1993-09

4.  Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse.

Authors:  Paula J Fite; Shaquanna Brown; Waheeda Hossain; Ann Manzardo; Merlin G Butler; Marco Bortolato
Journal:  CNS Neurosci Ther       Date:  2018-06-27       Impact factor: 5.243

5.  Early adolescent alcohol use and sexual experience by emerging adulthood: a 10-year longitudinal investigation.

Authors:  Amy Strachman; Emily A Impett; James Matthew Henson; Mary Ann Pentz
Journal:  J Adolesc Health       Date:  2009-05-30       Impact factor: 5.012

6.  A component-centered meta-analysis of family-based prevention programs for adolescent substance use.

Authors:  Mark J Van Ryzin; Cary J Roseth; Gregory M Fosco; You-Kyung Lee; I-Chien Chen
Journal:  Clin Psychol Rev       Date:  2016-04-03

Review 7.  Evolving prosocial and sustainable neighborhoods and communities.

Authors:  Anthony Biglan; Erika Hinds
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

Review 8.  Evolving the future: toward a science of intentional change.

Authors:  David Sloan Wilson; Steven C Hayes; Anthony Biglan; Dennis D Embry
Journal:  Behav Brain Sci       Date:  2014-05-15       Impact factor: 12.579

Review 9.  School-based programmes for preventing smoking.

Authors:  Roger E Thomas; Julie McLellan; Rafael Perera
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  The promise of long-term effectiveness of school-based smoking prevention programs: a critical review of reviews.

Authors:  Brian R Flay
Journal:  Tob Induc Dis       Date:  2009-03-26       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.